- Home
- PRME vs PRQR Comparison
PRME vs PRQR Comparison
Compare PRME & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- PRQR
- Stock Information
- Founded
- PRME 2019
- PRQR 2012
- Country
- PRME United States
- PRQR Netherlands
- Employees
- PRME N/A
- PRQR N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PRME Health Care
- PRQR Health Care
- Exchange
- PRME Nasdaq
- PRQR Nasdaq
- Market Cap
- PRME 379.1M
- PRQR 309.5M
- IPO Year
- PRME 2022
- PRQR 2014
- Fundamental
- Price
- PRME $2.97
- PRQR $2.56
- Analyst Decision
- PRME Strong Buy
- PRQR Strong Buy
- Analyst Count
- PRME 9
- PRQR 6
- Target Price
- PRME $13.13
- PRQR $8.17
- AVG Volume (30 Days)
- PRME 1.0M
- PRQR 296.6K
- Earning Date
- PRME 03-04-2025
- PRQR 03-12-2025
- Dividend Yield
- PRME N/A
- PRQR N/A
- EPS Growth
- PRME N/A
- PRQR N/A
- EPS
- PRME N/A
- PRQR N/A
- Revenue
- PRME $800,000.00
- PRQR $20,506,357.00
- Revenue This Year
- PRME N/A
- PRQR $210.18
- Revenue Next Year
- PRME $477.62
- PRQR $33.25
- P/E Ratio
- PRME N/A
- PRQR N/A
- Revenue Growth
- PRME N/A
- PRQR 306.68
- 52 Week Low
- PRME $2.25
- PRQR $1.61
- 52 Week High
- PRME $9.77
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PRME 53.25
- PRQR 56.93
- Support Level
- PRME $2.25
- PRQR $2.47
- Resistance Level
- PRME $3.36
- PRQR $2.67
- Average True Range (ATR)
- PRME 0.23
- PRQR 0.18
- MACD
- PRME 0.07
- PRQR 0.07
- Stochastic Oscillator
- PRME 64.41
- PRQR 83.58
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.